Olivier Mathieu/LinkedIn
Jul 9, 2026, 13:16
Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
Olivier Mathieu, Manager at Stago, shared a post on LinkedIn:
”Tomorrow’s routine assays were yesterday’s crazy ideas.
At isth2026, our Prospective Research Department team will be pleased to share concepts of new assays at the Stago scientific lounge.
Honored to showcase the work of an outstanding multidisciplinary team pushing innovation from early scientific ideas to future clinical applications to the benefit for patients.
Looking forward to engaging with the scientific community and bridging innovation with real-world needs in hemostasis.”
Stay updated with Hemostasis Today.
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery